Colorado BioScience Association Appoints Emily Martini as Vice President, Partnerships
By: Colorado BioScience Association Date: 08/22/2022
Martini to Lead Strategic Partnerships, Initiatives, and Programs in Newly Created Role Denver – Colorado BioScience Association (CBSA) announces the appointment of Emily Martini as Vice President of...
Learn MoreWeekly Policy Blog: President Biden Signs Inflation Reduction Act into Law
By: Colorado BioScience Association Date: 08/17/2022
On August 16, 2022, President Biden signed the Inflation Reduction Act, a bill aimed at addressing high inflationary costs. The massive bill increases corporate taxes and includes measures designed to...
Learn MoreWeekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements
By: Colorado BioScience Association Date: 08/12/2022
CBSA and our national partners support the renewal of the critically important User Fee Agreements, including the Pharmaceutical Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA)....
Learn MoreCBSA Remains Active on Critical Federal Legislation
By: Colorado BioScience Association Date: 08/05/2022
Act Today and Tell Your Member of Congress: Oppose Government Price Setting Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language t...
Learn MoreWeekly Policy Blog: CBSA’s Continued Advocacy on Important Federal Policy Initiatives
By: Colorado BioScience Association Date: 07/29/2022
Congress is negotiating sweeping legislation that impacts life sciences. Colorado BioScience Association (CBSA) remains active on these important legislative proposals, which include supporting the re...
Learn MoreFitzsimons Innovation Community Invests to Meet Market Needs
By: Colorado BioScience Association Date: 07/26/2022
Fitzsimons Innovation Community has maintained a fast pace of development over the past 10 years, building capacity to meet market needs. With an increase in the demand for move-in ready life sciences...
Learn MoreWeekly Policy Update: SBIR/STTR Critical to Life Sciences – Support Our Work on Reauthorization
By: Colorado BioScience Association Date: 07/22/2022
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to advance high-...
Learn MoreWeekly Policy Update: Where We Stand Today on Reauthorization of SBIR/STTR
By: Colorado BioScience Association Date: 07/08/2022
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to help advance...
Learn MoreWeekly Policy Update: CBSA Urges Repeal of Harmful R&D Amortization Provision
By: Colorado BioScience Association Date: 07/01/2022
Earlier this month, Colorado BioScience Association (CBSA) partnered with Biotechnology Innovation Organization (BIO) and sent a letter to Congress urging immediate legislative action to repeal the ha...
Learn MoreInvenux Accelerates Solutions for the Future of Rare Disease Patients
By: Colorado BioScience Association Date: 06/24/2022
Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a...
Learn More